Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions James Hodgins
Inmed PharmaceuticalsIN.TORISKYMay 15, 2018
James HodginsOwned
$1.01
Stock price when the opinion was issued
$4.19
As of May 07, 2021. Market Open.
0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
This is another company in the cannabis space. This is not a cannabis producer, it is a company that adds value in that space. They are mapping cannabinoids, looking for different formulations to treat different diseases.It is highly speculative, but he thinks there is opportunity for this type of company. He likes the management. In a growth market, as the US opens up, this could do very well. He owns stocks like this in a basket. He is not betting on any one of them; instead he is expecting the overall basket to do well.